Back To Search Results

Septate Uterus

Editor: Manvinder Singh Updated: 7/15/2023 12:43:26 AM

Introduction

In 2021, The American Society of Reproductive Medicine (ASRM) updated its Müllerian Anomaly Classification System (MAC2021) to update and expand prior classification systems in a manner that applies to all levels of healthcare providers and promotes patient awareness and advocacy. MAC2021 classifies Müllerian anomalies into 9 categories: Müllerian agenesis, cervical agenesis, unicornuate uterus, uterus didelphys, bicornuate uterus, septate uterus, longitudinal vaginal septum, transverse vaginal septum, and complex anomalies.[1] 

The septate uterus is the most commonly encountered Müllerian anomaly. ASRM defines a septate uterus with an indentation depth of >15 mm and an indentation angle of <90°. In contrast, The European Society of Human Reproduction and Embryology (ESHRE) defines a septate uterus using indentation-to-wall-thickness (I:WT) >50%, and the Congenital Uterine Malformation by Experts (CUME) suggest using an indentation depth of ≥1 cm.[2] 

Clinical determination of the need for surgical intervention for a septate uterus is challenging and controversial due to these varying yet accepted definitions.

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

The septate uterus is an anatomical anomaly resulting from the maldevelopment of the embryologic Müllerian, or paramesonephric, ducts. The specific cause of the anomaly is unknown. Attempts have been made to identify a genetic etiology of Müllerian anomalies, but a causal genetic relationship remains elusive. The etiology of Müllerian anomalies is thought to be multifactorial.[3]

Epidemiology

A septate uterus is the most commonly diagnosed congenital Müllerian anomaly, accounting for approximately 55% of such diagnoses.[4] The prevalence is estimated to be up to 1.5% in reproductive-age females. However, it is difficult to account for the prevalence of septate uteruses accurately; there are multiple accepted definitions, and many patients with the anomaly are asymptomatic.[5][6]

Pathophysiology

During the seventh week of female embryonic development, the absence of the Müllerian inhibitory factor triggers the regression of the mesonephric ducts and stimulates the development of two paramesonephric ducts.[7] These paramesonephric ducts eventually form the upper two-thirds of the vagina, cervix, uterus, and fallopian tubes.[8] The ovaries originate from the embryonic genital ridge.

In the eighth week of development, the paramesonephric ducts undergo a vertical fusion that creates a midline septum. By week 20 of embryonic development, the septum usually has undergone complete bidirectional resorption. If resorption is halted, the septum remains, and the uterus will be septate.[9] 

Resorption may be halted at any stage. If resorption is arrested early in development, the resulting septum creates a significant division of the endometrial cavity. If resorption is halted late in development, the septate uterus may only have a slight midline indentation; this is the arcuate or "heart-shaped" uterus, which appears to have no known clinical relevance.

Uterine septa may be partial, extending longitudinally from the uterine fundus without reaching the internal os, or they may be complete, extending from the uterine fundus to include the cervix. (Image 1, Partial and Complete Uterine Septa) Total resorption failure may result in a longitudinal vaginal septum with or without cervical duplication.

Thin uterine septa predominately comprise smooth muscle fibers and avascular fibrous tissue. Thickened muscular septa may have significant vasculature.[6]

Due to the timing of embryonic development, Müllerian anomalies are strongly associated with abnormalities of the upper and lower urinary tract; coexistence occurs in up to 40% of patients.[10] Although the concurrent incidence of uterine septa and renal anomalies lacks specific data, it is believed that renal anomalies are less frequently observed in cases involving impaired resorption rather than impaired fusion of the paramesonephric ducts. It is important to note that patients with isolated uterine septa do not require renal imaging unless otherwise indicated.[6]

History and Physical

A septate uterus is most likely to cause no symptoms and be found incidentally during pelvic imaging. Uterine septa are most likely to be identified after a first-trimester pregnancy loss, another adverse obstetrical outcome, or during cesarean section. A comprehensive obstetrical history is crucial when attempting to diagnose uterine septa.

There are no physical examination findings associated with isolated uterine septa.

Evaluation

The septate uterus may be visualized either directly during a diagnostic or therapeutic hysteroscopy or laparoscopy or indirectly via imaging studies such as ultrasonography (US), hysterosalpingography (HSG), or magnetic resonance imaging (MRI). 

Hysteroscopy

Hysteroscopy is the insertion of a rigid or flexible hysteroscope through the cervical canal into the endometrial cavity. Visualization of the entire endometrial cavity is accomplished using distention media. Hysteroscopy provides a complete view of the contour of the endometrial cavity, both tubal ostia; uterine septa are directly visualized if present.[11] However, hysteroscopy does not allow visualization of the contour of the serosal surface of the uterine fundus; a second imaging modality, such as concurrent ultrasound or laparoscopy, is needed to rule out a more significant uterine anomaly. 

Laparoscopy

Laparoscopy is a surgical procedure performed under general anesthesia that permits direct visualization of intraperitoneal abdominopelvic structures. Laparoscopy can be used in conjunction with hysteroscopy and HSG to visualize the fundal contour and identify the class of Mullerian anomaly. The method of using hysteroscopy and laparoscopy together has been shown to have the same diagnostic yield for a uterine septum as 3D ultrasound. Thus, 3D ultrasound is the preferable modality given the less invasive approach.[12]

Ultrasonography

A saline-infusion sonohystogram combines real-time uterine with the injection of sterile saline into the endometrial cavity to visualize its contour. [13] To measure a uterine septum during sonography, one line is drawn from cornu to cornu (line 1), and a second perpendicular line is drawn from line 1 to the tip of the septum (line 2). The length of line 2 is the septum measurement. In one study, sonohysterography was more sensitive and specific for a septate uterus than HSG and diagnostic hysteroscopy. There was no significant difference between HSG and diagnostic hysteroscopy.[4]

Hysterosalpingography (HSG) 

HSG is the radiologic imaging technique that facilitates structural evaluation of the endometrial cavity and fallopian tubes. Either oil- or water-based radiopaque contrast is delivered into the endometrial cavity under fluoroscopic guidance, and radiographs are taken.[14] A uterine septum may appear as an inverted triangular piece of tissue dividing the uterine cavity. However, the diagnostic accuracy of HSG in a septate uterus is low due to the difficulty distinguishing this finding from a bicornuate uterus.[6] Additionally, if the HSG reveals findings consistent with a septate uterus, this must be confirmed with 3D ultrasound, saline-infused sonogram, MRI, or laparoscopy to visualize the fundal contour and rule out a bicornuate uterus.

Magnetic Resonance Imaging (MRI) 

MRI of the pelvis using T2 images in three planes can measure a uterine septum. Long- and short-axis views are prescribed relative to the endometrium in the sagittal plane. The long-axis view allows visualization of the uterine fundal contour, while the short-axis view allows measurement of the uterine septum. To measure the uterine septum on MRI, you again measure from cornu to cornu (line 1) and measure from the caudal end of the uterine septum to the midpoint of line 1. A study by Ata et al determined that the ability of 3D ultrasound to diagnose a uterine septum is comparable to that of MRI but is the more cost-effective option.[15]

Treatment / Management

When a uterine septum is diagnosed in patients with infertility or a history of poor obstetrical outcomes, the recommended treatment is hysteroscopic resection of the septum. Many observational studies support this therapeutic regimen.[16] (A1)

However, there has been only one randomized controlled trial comparing hysteroscopic resection with expectant management in patients with a septate uterus. The Randomized Uterine Septum Transection (TRUST) trial randomized 80 patients with a septate uterus who desired pregnancy and had a history of subfertility, pregnancy loss, or preterm birth to either expectant management or septum resection. The two groups did not differ in time to pregnancy or live birth rate. The TRUST trial was limited by its small sample size, which included only 7 patients with a complete uterine septum. The study did not distinguish between septate and arcuate uteruses, which may have confounded their results.[17] (A1)

When a septate uterus is diagnosed in the absence of infertility or a history of a poor obstetrical outcome, septum resection can be considered with the appropriate patient counseling and shared decision-making.[6] The ideal timing of septum resection is during the early follicular phase of the menstrual cycle; the uterine lining is thin and does not obscure the hysteroscopic view. Medications such as progestins, danazol, or gonadotropin-releasing hormone (GnRH) agonists can suppress endometrial growth and facilitate hysteroscopic visualization of the uterine septum.

The goal of the hysteroscopic septal resection is to incise the uterine septum. Transection can be accomplished using cold scissors, unipolar or bipolar cautery, or argon lasers; success rates are similar for each.[18][19][20] Complications of this procedure are infrequent. A staged procedure is sometimes required if patients have a thick or complete uterine septum or a concurrent vaginal septum. [21] Ultrasound or fluoroscopic guidance can be used as an adjunct to prevent incising the myometrium.(A1)

Many techniques have been implemented to prevent intrauterine adhesions and septum reformation after hysteroscopic resection; no significant evidence suggests for or against any of these methods. Methods have included balloon stenting via intrauterine foley catheter placement, intrauterine injection of crosslinked hyaluronic gel, copper, or hormonal intrauterine device placement, and oral administration of estradiol or progestin.[22][23][24](A1)

Neither the Jones nor Tompkins metroplasty is frequently performed in current clinical practice; abdominal hysterotomy with subsequent resection of the uterine septum and metroplasty is an invasive procedure with significant surgical and obstetrical risk.[25]

Differential Diagnosis

The differential diagnosis of a septate uterus includes an arcuate uterus, bicornuate uterus, or uterus didelphys.

Prognosis

Uterine septa are associated with poor reproductive outcomes, including recurrent pregnancy loss and preterm delivery. There is conflicting evidence regarding the association of uterine septa with infertility. However, observational studies have indicated that surgical septum resection can improve clinical pregnancy rates in infertile couples and improve pregnancy outcomes in those with prior miscarriages or preterm deliveries.[6][25]

Complications

Many patients with a septate uterus do not experience any adverse reproductive sequelae. However, the most common adverse reproductive outcome of a septate uterus is infertility or preterm delivery. For each pregnancy that develops within a septate uterus, there is a 26% to 94% chance of miscarriage and a 6% to 16% chance of preterm labor.[4]

A review article found that congenital anomalies were identified in 12.6% of patients with recurrent pregnancy loss.[26] In observational studies, patients with a septate uterus were found to have higher rates of first-trimester miscarriage than those with a normal uterine cavity (42% vs 12%); however, a septate uterus did not increase the risk of a second-trimester miscarriage or preterm labor.[27]

There is some observational evidence that a septate uterus may increase the risk for fetal malpresentation, intrauterine growth restriction, placental abruption, and perinatal mortality. However, there have not been large randomized controlled trials to evaluate these outcomes.[6]

The complications of a hysteroscopic septum resection include uterine perforation, resulting injury to surrounding pelvic structures, and intrauterine adhesion formation. The risk of uterine perforation can be minimized by using intraoperative ultrasound guidance. The formation of postoperative intrauterine adhesions may be minimized with prophylactic hormone replacement therapy or intrauterine balloon placement; data is inclusive.

Case reports have described intrapartum uterine rupture following hysteroscopic septum resection; uterine rupture may have been due to inadvertent myometrial incision during the resection procedure. A recent 20-year retrospective analysis in Slovenia found 4 cases of uterine rupture in patients who achieved term pregnancy after undergoing hysteroscopic uterine septum resection.[28] Avoiding myometrial incision through judicious septal transection may prevent this catastrophic complication.

Deterrence and Patient Education

A septate uterus is associated with poor obstetrical outcomes and may contribute to female infertility. Diagnosing a uterine septum in a patient with prior pregnancy losses or undergoing a fertility workup is essential, as its repair via hysteroscopic resection can lead to improved pregnancy outcomes.

Enhancing Healthcare Team Outcomes

Collaborative efforts and comprehensive care can improve outcomes for patients with a septate uterus. The interprofessional team of physicians, including surgeons, reproductive endocrinologists or fertility specialists, and radiologists, in conjunction with nurses, embryologists, and other healthcare professionals, are responsible for developing a treatment plan that meets the specific needs and goals of each patient. Obtaining a comprehensive medical history with a particular focus on the obstetrical history, performing a physical examination, and evidence-based utilization of diagnostic imaging and surgical modalities are the essential components of comprehensive care for patients with a septate uterus.

Media


(Click Image to Enlarge)
(A) 3D ultrasound coronal view of partial septate uterus,  (B) 3D ultrasound coronal view of a complete septate uterus, (C) U
(A) 3D ultrasound coronal view of partial septate uterus, (B) 3D ultrasound coronal view of a complete septate uterus, (C) Ultrasound transverse view of a complete septate uterus, (D) 3D ultrasound coronal view of an arcuate uterus, (E) Ultrasound coronal view of bicornuate uterus, (F) MRI image of bicornuate uterus
Images A-D contributed by Jenna Kahn, MD and Imagees E, F contributed by Laveena Kondagari, MD

References


[1]

Pfeifer SM, Attaran M, Goldstein J, Lindheim SR, Petrozza JC, Rackow BW, Siegelman E, Troiano R, Winter T, Zuckerman A, Ramaiah SD. ASRM müllerian anomalies classification 2021. Fertility and sterility. 2021 Nov:116(5):1238-1252. doi: 10.1016/j.fertnstert.2021.09.025. Epub     [PubMed PMID: 34756327]


[2]

Ludwin A, Martins WP, Nastri CO, Ludwin I, Coelho Neto MA, Leitão VM, Acién M, Alcazar JL, Benacerraf B, Condous G, De Wilde RL, Emanuel MH, Gibbons W, Guerriero S, Hurd WW, Levine D, Lindheim S, Pellicer A, Petraglia F, Saridogan E. Congenital Uterine Malformation by Experts (CUME): better criteria for distinguishing between normal/arcuate and septate uterus? Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2018 Jan:51(1):101-109. doi: 10.1002/uog.18923. Epub     [PubMed PMID: 29024135]


[3]

Jacquinet A, Millar D, Lehman A. Etiologies of uterine malformations. American journal of medical genetics. Part A. 2016 Aug:170(8):2141-72. doi: 10.1002/ajmg.a.37775. Epub 2016 Jun 8     [PubMed PMID: 27273803]


[4]

Ludwin A, Ludwin I, Banas T, Knafel A, Miedzyblocki M, Basta A. Diagnostic accuracy of sonohysterography, hysterosalpingography and diagnostic hysteroscopy in diagnosis of arcuate, septate and bicornuate uterus. The journal of obstetrics and gynaecology research. 2011 Mar:37(3):178-86. doi: 10.1111/j.1447-0756.2010.01304.x. Epub 2011 Feb 11     [PubMed PMID: 21314802]


[5]

Rikken J, Leeuwis-Fedorovich NE, Letteboer S, Emanuel MH, Limpens J, van der Veen F, Goddijn M, van Wely M. The pathophysiology of the septate uterus: a systematic review. BJOG : an international journal of obstetrics and gynaecology. 2019 Sep:126(10):1192-1199. doi: 10.1111/1471-0528.15798. Epub 2019 May 15     [PubMed PMID: 31004459]

Level 1 (high-level) evidence

[6]

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertility and sterility. 2016 Sep 1:106(3):530-40. doi: 10.1016/j.fertnstert.2016.05.014. Epub 2016 May 25     [PubMed PMID: 27235766]


[7]

Passos IMPE, Britto RL. Diagnosis and treatment of müllerian malformations. Taiwanese journal of obstetrics & gynecology. 2020 Mar:59(2):183-188. doi: 10.1016/j.tjog.2020.01.003. Epub     [PubMed PMID: 32127135]


[8]

Robbins JB, Broadwell C, Chow LC, Parry JP, Sadowski EA. Müllerian duct anomalies: embryological development, classification, and MRI assessment. Journal of magnetic resonance imaging : JMRI. 2015 Jan:41(1):1-12. doi: 10.1002/jmri.24771. Epub 2014 Oct 7     [PubMed PMID: 25288098]


[9]

Moncada-Madrazo M, Rodríguez Valero C. Embryology, Uterus. StatPearls. 2023 Jan:():     [PubMed PMID: 31613528]


[10]

Wu CQ, Childress KJ, Traore EJ, Smith EA. A Review of Mullerian Anomalies and Their Urologic Associations. Urology. 2021 May:151():98-106. doi: 10.1016/j.urology.2020.04.088. Epub 2020 May 6     [PubMed PMID: 32387292]


[11]

Moore JF, Carugno J. Hysteroscopy. StatPearls. 2023 Jan:():     [PubMed PMID: 33232015]


[12]

Ludwin A, Pityński K, Ludwin I, Banas T, Knafel A. Two- and three-dimensional ultrasonography and sonohysterography versus hysteroscopy with laparoscopy in the differential diagnosis of septate, bicornuate, and arcuate uteri. Journal of minimally invasive gynecology. 2013 Jan-Feb:20(1):90-9. doi: 10.1016/j.jmig.2012.09.011. Epub     [PubMed PMID: 23312248]


[13]

American College of Obstetrics and Gynecologist Tecnology Assessment. Saline infusion sonohysterography. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2004 Jan:84(1):95-8     [PubMed PMID: 14968760]

Level 1 (high-level) evidence

[14]

Baramki TA. Hysterosalpingography. Fertility and sterility. 2005 Jun:83(6):1595-606     [PubMed PMID: 15950625]


[15]

Ata B, Nayot D, Nedelchev A, Reinhold C, Tulandi T. Do measurements of uterine septum using three-dimensional ultrasound and magnetic resonance imaging agree? Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC. 2014 Apr:36(4):331-338. doi: 10.1016/S1701-2163(15)30609-5. Epub     [PubMed PMID: 24798671]


[16]

Krishnan M, Narice BF, Ola B, Metwally M. Does hysteroscopic resection of uterine septum improve reproductive outcomes: a systematic review and meta-analysis. Archives of gynecology and obstetrics. 2021 May:303(5):1131-1142. doi: 10.1007/s00404-021-05975-2. Epub 2021 Feb 7     [PubMed PMID: 33550465]

Level 1 (high-level) evidence

[17]

Rikken JFW, Kowalik CR, Emanuel MH, Bongers MY, Spinder T, Jansen FW, Mulders AGMGJ, Padmehr R, Clark TJ, van Vliet HA, Stephenson MD, van der Veen F, Mol BWJ, van Wely M, Goddijn M. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial. Human reproduction (Oxford, England). 2021 Apr 20:36(5):1260-1267. doi: 10.1093/humrep/deab037. Epub     [PubMed PMID: 33793794]

Level 1 (high-level) evidence

[18]

Candiani GB, Vercellini P, Fedele L, Garsia S, Brioschi D, Villa L. Argon laser versus microscissors for hysteroscopic incision of uterine septa. American journal of obstetrics and gynecology. 1991 Jan:164(1 Pt 1):87-90     [PubMed PMID: 1986632]

Level 1 (high-level) evidence

[19]

Vercellini P, Vendola N, Colombo A, Passadore C, Trespidi L, Fedele L. Hysteroscopic metroplasty with resectoscope or microscissors for the correction of septate uterus. Surgery, gynecology & obstetrics. 1993 May:176(5):439-42     [PubMed PMID: 8480265]

Level 1 (high-level) evidence

[20]

Colacurci N, De Franciscis P, Mollo A, Litta P, Perino A, Cobellis L, De Placido G. Small-diameter hysteroscopy with Versapoint versus resectoscopy with a unipolar knife for the treatment of septate uterus: a prospective randomized study. Journal of minimally invasive gynecology. 2007 Sep-Oct:14(5):622-7     [PubMed PMID: 17848325]

Level 1 (high-level) evidence

[21]

Wang S, Shi X, Hua X, Gu X, Yang D. Hysteroscopic transcervical resection of uterine septum. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2013 Oct-Dec:17(4):517-20. doi: 10.4293/108680813X13753907291954. Epub     [PubMed PMID: 24398191]


[22]

Guida M, Acunzo G, Di Spiezio Sardo A, Bifulco G, Piccoli R, Pellicano M, Cerrota G, Cirillo D, Nappi C. Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Human reproduction (Oxford, England). 2004 Jun:19(6):1461-4     [PubMed PMID: 15105384]

Level 1 (high-level) evidence

[23]

Vercellini P, Fedele L, Arcaini L, Rognoni MT, Candiani GB. Value of intrauterine device insertion and estrogen administration after hysteroscopic metroplasty. The Journal of reproductive medicine. 1989 Jul:34(7):447-50     [PubMed PMID: 2549238]


[24]

Tonguc EA, Var T, Yilmaz N, Batioglu S. Intrauterine device or estrogen treatment after hysteroscopic uterine septum resection. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2010 Jun:109(3):226-9. doi: 10.1016/j.ijgo.2009.12.015. Epub 2010 Feb 11     [PubMed PMID: 20152976]


[25]

Budden A, Abbott JA. The Diagnosis and Surgical Approach of Uterine Septa. Journal of minimally invasive gynecology. 2018 Feb:25(2):209-217. doi: 10.1016/j.jmig.2017.07.017. Epub 2017 Jul 26     [PubMed PMID: 28755995]


[26]

Turocy JM, Rackow BW. Uterine factor in recurrent pregnancy loss. Seminars in perinatology. 2019 Mar:43(2):74-79. doi: 10.1053/j.semperi.2018.12.003. Epub 2018 Dec 20     [PubMed PMID: 30683511]


[27]

Shuiqing M, Xuming B, Jinghe L. Pregnancy and its outcome in women with malformed uterus. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih. 2002 Dec:17(4):242-5     [PubMed PMID: 12901513]

Level 2 (mid-level) evidence

[28]

Jansa V, Laganà AS, Ferrari F, Ghezzi F, Burnik Papler T, Vrtacnik Bokal E, Ban Frangež H. Uterine rupture in pregnancy after hysteroscopic septum resection: a 20-year retrospective analysis. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy. 2022 Mar:31(3):448-455. doi: 10.1080/13645706.2020.1837884. Epub 2020 Dec 17     [PubMed PMID: 33331203]

Level 2 (mid-level) evidence